Patent & IP news for January 3, 2017

Top Stories of 2016: #16 to #20 from www.patentdocs.org

By Donald Zuhn –- After reflecting upon the events of the past twelve months, Patent Docs presents its tenth annual list of top patent stories. For 2016, we identified twenty stories that were covered on Patent ...

Share via E–mail | Twitter | Facebook

Drug patents, lemmings, and urban legends from ipbiz.blogspot.com

A post in medcitynews, titled Drug patents expiring in 2017? It’s all smoke and mirrors , has within the beginning text:


Once upon a time, reporters could definitively track down what drug patents would expire ...

Share via E–mail | Twitter | Facebook

The issue of two competing drugs for a single condition, with one offered at a significantly cheaper price from ipbiz.blogspot.com


Of the "drug patent" matter discussed in medcitynews, the recent flurry of excitement in the MS community over the drug Ocrelizumab brings up another issue [that of two competing drugs for a single condition, with ...

Share via E–mail | Twitter | Facebook

Roundtable: ‘Appropriate Level’ Of Protection Is Key For Impact Of Patents In Health, Innovation from www.ip-watch.org

One of the key questions around the impact of patents on health and innovation is what is the appropriate level of protection for companies innovating, says Dr. Marie-Paul Kieny, assistant director-general, Health Systems and Innovation ...

Share via E–mail | Twitter | Facebook

Defendant's Failure to Assert Counterclaims Undermines Request for Rule 11 Sanctions from docketreport.blogspot.com

Following plaintiff's voluntary dismissal of its patent infringement action, the court denied defendant's motion for sanctions under Rule 11 on the ground that plaintiff's claims were baseless. "[Defendant's] underlying contentions -- that ...

Share via E–mail | Twitter | Facebook

More on urban legends; the New York Times on "Our Miss Brooks" and the transistor from ipbiz.blogspot.com

As illustrated in the IPBiz post of 3 January 2017 titled Drug patents, lemmings, and urban legends , urban legends, such as the suicidal lemmings, can persist for years after they have been de-bunked.

In the ...

Share via E–mail | Twitter | Facebook

UK Will Ratify UPC Despite Brexit from www.iplawalert.com

Recently, the UK Minister of State for Intellectual Property, Baroness Neville-Rolfe, announced that the UK will implement the Unitary Patent (UP) and Unified Patent Court (UPC). In the announcement, Neville-Rolfe both praised the UP/UPC ...

Share via E–mail | Twitter | Facebook

Oral argument of the week: MACROPOINT v. FOURKITES from www.717madisonplace.com

The oral argument of the week is MACROPOINT, LLC v. FOURKITES, INC., No. 2016-1286 (Fed. Cir. Dec. 8, 2016) decided by a Rule 36 judgment.  The case focuses primarily on §101 issues. You can listen ...

Share via E–mail | Twitter | Facebook

USTR Nominee Lighthizer May Fit Strong Stance On IP Protection from www.ip-watch.org

Robert Lighthizer, President-elect Donald Trump's newly named choice for United States Trade Representative, appears to fit Trump's strong stance on China, including on intellectual property protection, but is a longstanding Washington Republican insider ...

Share via E–mail | Twitter | Facebook

Federal Circuit: obviousness requires a clear and explicit explanation from ipspotlight.com

The Federal Circuit recently vacated a Patent Trial and Appeals Board (PTAB) decision that found obvious several claims of a patent application relating to methods for re-configuring icons on a touch-sensitive display. In In re ...

Share via E–mail | Twitter | Facebook